Starving our microbial self: The deleterious consequences of a diet deficient in microbiota-accessible carbohydrates
Influence of glycyrrhizin on permeability and elasticity of cell membrane: perspectives for drugs delivery
14 BrownEHeerspinkHJLCuthbertsonDJWildingJPH
"The GLP-1 program helped me lose 30 pounds in 4 months
The efficacy and safety of weekly semaglutide (2.4 mg) for the treatment of overweight and obesity was investigated in the Semaglutide Treatment Effect in People with Obesity (STEP) programme, which included individuals with overweight (BMI 27 kg/m 2 ) and complications, including dyslipidaemia, hypertension, sleep apnoea, cardiovascular disease and type 2 diabetes, or individuals with obesity (BMI 30 kg/m 2 ) with or without complications [26, 34,35,36,37,38,39]
It does not represent approval for mass-market cosmetic applications